baber/WOPTO huggingface dataset:
Patent AU-2011347578-B2 (AU)
Title: High-gloss surface by means of hot-coating
Inventor: BECKER-WEIMANN KLAUS
IPC: B05D1/30
Filed: 2011-12-19
Granted: 2016-11-03
Abstract: The invention relates to a method for generating high-gloss surfaces on at least a part of a carrier surface, comprising the following steps: (a) applying a layer made of a molten mass to at least a part of the carrier surface; (b) smoothing the applied molten mass layer; (c) applying at least one paint layer to the smoothed molten mass layer by means of curtain coating methods; and (d) curing the applied layer composition. The invention further relates to objects which can be obtained according to such a method.
Patent AU-2011366189-B2 (AU)
Title: Method of setting transmission shift points in real-time based upon an engine performance curve
Inventor: ETCHASON EDMOND M
IPC: F16H61/04
Filed: 2011-04-22
Granted: 2016-07-28
Abstract: The present invention provides a method for setting a shift point for shifting a transmission for a powered vehicle between a first gear ratio and a second gear ratio. The method includes determining input power data points based on real-time input torque data. The input torque data includes a maximum input torque. The method also includes calculating a gear step value based on the first gear ratio and second gear ratio. The method further includes determining a first power value and computing a second power value based on the gear step value. The first power value and second power value are compared to one another and adjustments are incrementally made in the first power value speed until the difference between first and second power values meets a threshold. The shift point is therefore based on the result of comparing the first power value and the second power value and the corresponding speed associated with the first power value.
Patent AU-2012201972-B2 (AU)
Title: Methods and system of automating track circuit calibration
Inventor: LAWSON RICHARD LEE
IPC: B61L1/20
Filed: 2012-04-04
Granted: 2015-03-26
Abstract: This application relates to a method for calibrating a track circuit as provided. The track circuit includes a transmit processing unit, a receive processing unit, a plurality 5 of rails coupled in series to form a track section having a first end and a second end. The transmit processing unit is coupled to the track section adjacent the first end. The receive processing unit is coupled to the track section adjacent the second end. The method includes operating the transmit processing u nit so that a first voltage is applied to the track section, operating the receive processing unit to detect a first current 10 signal, and if a parameter of the first current signal is not within a predetermined range, then communicating with the transmit processing unit so that the transmit processing unit automatically applied a second voltage to the tract section, the second voltage having a different magnitude than the first voltage. 938703>
Patent AU-2012202575-B2 (AU)
Title: Treatment for Multiple Sclerosis
Inventor: PANZARA MICHAEL
IPC: A61K38/21
Filed: 2012-05-02
Granted: 2014-11-20
Abstract: Methods of treating multiple sclerosis and other disorders are disclosed.
Patent AU-2012203304-B2 (AU)
Title: Stacked organic photosensitive devices
Inventor: RAND BARRY P
IPC: H01L27/30
Filed: 2012-06-05
Granted: 2013-05-16
Abstract: A device is provided having a first electrode, a second electrode, a first photoactive region having a characteristic absorption wavelength X1 and a second photoactive 5 region having a characteristic absorption wavelength X2. The photoactive regions are disposed between the first and second electrodes, and further positioned on the same side of a reflective layer, such that the first photoactive region is closer to the reflective layer than the second photoactive region. The materials comprising the photoactive regions may be selected such that X1 is at least about 10% different from X2. The device may further comprise an exciton 0 blocking layer disposed adjacent to and in direct contact with the organic acceptor material of each photoactive region, wherein the LUMO of each exciton blocking layer other than that closest to the cathode is not more than about 0.3 eV greater than the LUMO of the acceptor material.
Patent AU-2012207153-B2 (AU)
Title: Methods, systems and apparatuses for sensing and measuring the electric field within the earth
Inventor: HIBBS ANDREW DENNIS
IPC: G01R27/26
Filed: 2012-01-20
Granted: 2016-06-30
Abstract: Methods, systems, and apparatuses for measuring an electric potential in the earth, which includes a first sensor are disclosed. The first sensor includes a sensing plate for placement in an environment in close proximity to the earth. The sensing plate has an operative capacitive coupling with the earth and measures the earth's electric potential, The sensor also includes a barrier providing electrochemical segregation between the sensing plate and the earth and an amplifier having at least one stage for receiving and amplifying a first signal carrying the potential measured by the sensing plate. The sensor also includes a first connection carrying the first signal from the sensing plate to the amplifier; and a reference voltage for application to the first stage of the amplifier, the reference voltage providing a reference against which the potential measured by the sensing plate is compared.. Other embodiments are described and claimed.
Patent AU-2012209853-B2 (AU)
Title: Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
Inventor: HIRAOKA SHOGO
IPC: A61K9/19
Filed: 2012-01-17
Granted: 2016-06-16
Abstract: The present invention provides a medical device containing a cake composition comprising aripiprazole as an active ingredient and capable of suppressing agglomeration of aripiprazole in a suspension obtained by resuspending a freeze-dried substance; and a cake composition comprising aripiprazole as an active ingredient. The present invention relates to a medical device containing, in a storage container whose inner wall is treated with silicone, a freeze-dried cake composition comprising separately prepared aripiprazole as an active ingredient, wherein there is a space between the inner wall and the cake composition; and a cake composition comprising aripiprazole as an active ingredient and having a strength of 5 to 100 N.
Patent AU-2012264385-B2 (AU)
Title: Dispersion and detachment of cell aggregates
Inventor: ZLOTKIN AMIR
IPC: A01N63/50
Filed: 2012-05-31
Granted: 2018-06-28
Abstract: Compositions comprising a protein or isolated peptide, and methods using the same for preventing, dispersing or detaching a biofilm, are disclosed.
Patent AU-2012308091-B2 (AU)
Title: Composite cannula
Inventor: AESCHLIMANN ANDREAS
IPC: A61M5/00
Filed: 2012-09-12
Granted: 2015-01-22
Abstract: The present invention provides a cannula comprising of a core needle and a sleeve, the core needle and sleeve spaced by conduit-forming projections. The projections may be aligned axially along the surface of the core needle or the inner surface of the sleeve. Engagement of the core needle with a sleeve forms a composite needle having one or multiple conduits for fluid transfer the length of the cannula. Engagement of the core needle and sleeve may be enhanced with different engagement means. Preferably the core needle and sleeve comprise of polymeric materials. The invention most advantageously can be produced without the need for a core pin in the formation of the core needle or sleeve. A composite needle may incorporate a sharp tip for penetration of materials and a side port for transfer of fluids. Alternatively, the composite needle may be blunt at the tip.
Patent AU-2012314129-B2 (AU)
Title: A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
Inventor: WHALLEY BENJAMIN
IPC: A61K31/05
Filed: 2012-09-14
Granted: 2017-08-31
Abstract: This invention relates to a pharmaceutical composition comprising or consisting essentially of the phytocannabinoids cannabidivarin (CBDV)and cannabidiol (CBD). The composition is particularly safe and efficacious for use in the treatment of neurological conditions, characterized by hyper-excitability of the central nervous system, convulsions or seizures such as occur in epilepsy. Preferably the CBDV and the CBD are present with at least one non- cannabinoid component of cannabis such as one or more terpenes or a terpene fraction. More particularly the composition further comprises one or more cannabichromene type compounds. Particularly cannabichromene propyl variant (CBCV) and / or cannabichromene (CBC).More particularly still the composition is absent or substantially absent of other cannabinoids, including in particular tetrahydrocannabinol (THC) and tetrahydrocannabivarin (THCV), which would normally be present in significant amounts in cannabis chemotypes bred to contain a significant amount of CBDV and / or CBD.
Patent AU-2012349863-B2 (AU)
Title: Respiratory infection assay
Inventor: CURRAN MARTIN
IPC: C12Q1/70
Filed: 2012-12-10
Granted: 2017-07-13
Abstract: The present invention provides nucleic acid products and corresponding methods for screening a biological sample for the presence of a respiratory infection-causing microorganism, using real-time PCR and a test card having detection probes in separate wells.
Patent AU-2012356350-B2 (AU)
Title: Control system for internal combustion engine and inert gas concentration detecting device for compressed natural gas
Inventor: SUGIYAMA KOUSEKI
IPC: F02D41/38
Filed: 2012-12-19
Granted: 2015-07-30
Abstract: In a control system that includes a pressure accumulating portion that supplies CNG to a fuel injection valve and a regulator that adjusts a pressure in the pressure accumulating portion to a set pressure and of which a valve element opens when CNG is supplied to the pressure accumulating portion and closes when supply of CNG to the pressure accumulating portion is shut off, a control parameter relating to a combustion state in an internal combustion engine is controlled (S105) on the basis of a length of a period (Δtv) during which an opening degree of the valve element reduces from a first predetermined opening degree to a second predetermined opening degree (S102) when the pressure in the pressure accumulating portion is adjusted to the set pressure by the regulator.
Patent AU-2012364357-B2 (AU)
Title: Appliance for drying laundry
Inventor: CONTARINI ANDREA
IPC: D06F58/28
Filed: 2012-12-28
Granted: 2017-01-19
Abstract: Appliance for drying laundry (100), comprising a drying-air moisture-condensing system comprising a heat pump system (215, 220, 225) with a first heat exchanger (215) for cooling the drying air and a second heat exchanger (220) for re-heating said drying air, and a variable-output compressor (210), and at least one Joule-effect heater (255) located downstream the heat pump heat exchangers for boosting the heating of the drying air. The appliance can perform at least one drying cycle in: at least a first drying mode, wherein said heater is kept de-energized and the compressor is driven to a first compressor mode having a compressor power consumption course and/or a compressor rotational speed course and/or a frequency course of the supply current/voltage of the compressor motor, and at least a second drying mode, wherein said heater is kept energized for at least an initial portion of the drying cycle and thereafter it is kept de-energized, and the compressor is driven to a second compressor mode comprising a compressor power consumption course and/or a compressor rotational speed course and/or a frequency course of the supply current/voltage of the compressor motor, wherein for at least a portion of the drying cycle after the electric heater has been de-energized, a compressor power consumption and/or a compressor rotational speed and/or a frequency of the supply currentlvoltage of the compressor of the second compressor mode is/are higher than the one/s of the first compressor mode.
Patent AU-2012395834-B2 (AU)
Title: A method and assembly for the production of hydrogen gas
Inventor: WONG SONG YENG
IPC: C01B3/02
Filed: 2012-11-27
Granted: 2017-05-25
Abstract: Provided is a process for producing hydrogen gas in a separate stream from syngas. An assembly for producing hydrogen gas in a separate stream from syngas and a method of producing hydrogen are also provided.
Patent AU-2013202237-B2 (AU)
Title: Voltammetric systems for assaying biological analytes
Inventor: WU HUAN-PING
IPC: G01N33/487
Filed: 2013-04-02
Granted: 2015-03-05
Abstract: The present invention relates to systems, methods, and devices for determining the concentration of an analyte in a sample. The use of linear, cyclic, or acyclic voltammetric scans and/or semi-integral, derivative, or semi-derivative data treatment may provide for increased accuracy when determining the concentration of an analyte in a sample. Hematocrit compensation in combination with the data treatments may reduce the hematocrit effect with regard to a glucose analysis in whole blood. In another aspect, fast scan rates may reduce the hematocrit effect.
Patent AU-2013226400-B2 (AU)
Title: Methods for predicting anti-cancer response
Inventor: SILVER DANIEL
IPC: G01N33/574
Filed: 2013-02-22
Granted: 2018-09-06
Abstract: The present invention relates to methods for predicting response of a cancer in a subject to anti-cancer therapies based upon a determination and analysis of a chromosomal aberration score, such as the number of allelic imbalance or the number of telomeric allelic imbalance in the chromosomes of the human genome.
Patent AU-2013231125-B2 (AU)
Title: System for inducing desirable temperature effects on body tissue
Inventor: BLANCK ARTHUR G
IPC: A61B18/14
Filed: 2013-09-20
Granted: 2015-08-20
Abstract: SYSTEM FOR INDUCING DESIRABLE TEMPERATURE EFFECTS ON BODY TISSUE There is disclosed herein a system for inducing desirable temperature effects on a target body tissue disposed about a blood vessel, the system comprising: a catheter body having a proximal end and a distal end with an axis therebetween; a radially expandable member supported by the distal end of the catheter body, the expandable member having a low profile insertion configuration and a larger profile configuration; and a plurality of electrodes included on a plurality of separate flexible circuits each attached to an outer surface of the expandable member so as to radially couple with a wall of the blood vessel and define a plurality of remodeling zones in a tissue treatment area when the expandable member is in the large profile configuration within the blood vessel, wherein the plurality of electrodes are distributed circumferentially about the balloon such that the plurality of remodeling zones extend about the circumference of the blood vessel, wherein each of the plurality of flexible circuits includes a polymeric substrate supporting at least one pair of electrodes; wherein the plurality of electrodes are configured to transmit a tissue remodeling energy to each of the plurality of remodeling zones such that when at least some remodeling zones of the plurality include collateral tissue without the target body tissue, the tissue remodeling energy is transmitted to the at least some remodeling zones heating the collateral tissue without causing thermal damage, while the tissue remodeling energy transmitted to remodeling zones including both the target tissue and collateral tissue heats the target tissue sufficiently to efficaciously alter the target tissue without causing thermal damage to the collateral healthy tissue.
Patent AU-2013232107-B2 (AU)
Title: Neurostimulation system for preventing magnetically induced currents in electronic circuitry
Inventor: GURURAJ KIRAN
IPC: A61N1/08
Filed: 2013-03-13
Granted: 2015-11-19
Abstract: A neurostimulation device capable of being placed between an active stimulation state and an inactive stimulation state and method of using same. The neurostimulation device comprises a plurality of electrical terminals configured for being respectively coupled to a plurality of stimulation electrodes, a first solid-state switching device coupled to a first one of the electrical terminals, a variable power source coupled to the first switching device, and a controller configured for, when the neurostimulation device is in the inactive stimulation state, prompting the variable power source to selectively output a relatively low voltage to place the first switching device into a first open state and a relatively high voltage to place the first switching device into a second open state.
Patent AU-2013251814-B2 (AU)
Title: Method and arrangement of measuring a mechanical bearing oscillation
Inventor: ERSKINE JOSEPH
IPC: G01M17/10
Filed: 2013-04-17
Granted: 2015-12-03
Abstract: Embodiments relate to an arrangement (101) and a method of measuring a mechanical bearing oscillation within a bearing (109), the bearing supporting a rotating shaft (103) which is coupled to an inner ring (107) of the bearing (109), the arrangement comprising: a bolt (119) arranged in a force fit with an outer ring (123) of the bearing (109) in order to excite, by the bearing oscillation, a bolt oscillation; a sensor (121) mechanically coupled to the bolt (119) for registering the bolt oscillation, the bolt oscillation being indicative of the bearing oscillation.
Patent AU-2013267325-B2 (AU)
Title: Synthesis of pyrrolo (2, 3 - b) pyridines
Inventor: IBRAHIM PRABHA N
IPC: C07D471/04
Filed: 2013-05-30
Granted: 2017-11-02
Abstract: Provided herein are intermediates and processes useful for facile synthesis of biologically active molecules.
Patent AU-2013273686-B2 (AU)
Title: Image coding method, image decoding method, image coding apparatus, image decoding apparatus, and image coding and decoding apparatus
Inventor: MATSUNOBU TORU
IPC: H04N19/50
Filed: 2013-06-10
Granted: 2017-03-02
Abstract: Ar image coding method includes performing: context arithmetic coding (5711) to consecutively code (i) first information indicating whether or not to perform SAO processing for a first region 5 and (ii) second information indicating whether or not to use, in the SAO processing for the frst region, information on SAO processing for a region except the first region; and bypass arithmetic coding (5712) to code other information after the first and second information are coded. The other information indudes third 10 information indicating whether the SAO processing is edge or band offset processing. In the performing of context arithmetic coding (5711), an initial bit value in a bit string of a parameter indicating a type of the SAO processing is coded as the first information. In the performing of bypass arithmetic coding (5712), a value of a next bit 15 following the initial bit in the bit string of the parameter is coded as the third information 1 i13 -
Patent AU-2013325599-B2 (AU)
Title: Facilitated CO2 transport membrane and method for producing same, and method and apparatus for separating CO2
Inventor: OKADA OSAMU
IPC: C01B32/50
Filed: 2013-10-01
Granted: 2016-04-28
Abstract: Provided is a facilitated CO
Patent AU-2013329910-B2 (AU)
Title: Nucleated polypropylene composition for containers
Inventor: JOHNSEN GEIR KRISTIAN
IPC: B65D1/26
Filed: 2013-08-02
Granted: 2016-05-05
Abstract: The present invention provides a moulded container for food packaging comprising, preferably consisting of, a polypropylene composition, the polypropylene composition comprising - a propylene homo- or copolymer (A) having (i) a melt flow rate, determined according to ISO 1133 at 230 °C and under a load of 2.16 kg, of at least 25 g/10 min; and (ii) in case component (A) is a copolymer, a comonomer content of not more than 5.0 wt.%; and a nucleating agent (B), as well as to the use of a polypropylene composition comprising - a propylene homo- or copolymer (A) having (i) a melt flow rate, determined according to ISO 1133 at 230°C and under a load of 2.16 kg, of at least 25 g/10 min; and (ii) in case component (A) is a copolymer, a comonomer content of not more than 5.0 wt.%; and a nucleating agent (B); for the manufacture of a moulded container.
Patent AU-2013346322-B2 (AU)
Title: Crystalline Bortezomib process
Inventor: SHRAWAT VIMAL KUMAR
IPC: A61K31/517
Filed: 2013-11-12
Granted: 2016-11-10
Abstract: The present invention provides process for preparation of crystalline Bortezomib (Ia) as its monohydrate which is designated as crystalline Form-SB (Ia) and characterized by having water content ranging between 3.5 - 6.0 %
Patent AU-2013359247-B2 (AU)
Title: Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates
Inventor: GIAMPIETRO NATALIE C
IPC: C07D213/61
Filed: 2013-12-12
Granted: 2016-02-18
Abstract: 4-Amino-5-fluoro-3-chloro-6-(substituted)picolinates are prepared from trifluoroacetic acid, p-methoxyaniline, a C1-C4 alkyl propiolate and a substituted methylene amine by a series of steps. In particular, provided herein are processes for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates from a non-pyridine source without a metal assisted coupling and without fluorination with an expensive fluorinating agent. These picolinates are useful as herbicides.
Patent AU-2014229014-B2 (AU)
Title: Modified surface energy non-woven filter element
Inventor: PATEL SHAGUFTA
IPC: B01D63/10
Filed: 2014-03-14
Granted: 2018-07-12
Abstract: A non-woven low surface energy filter element designed to have improved removal of a dispersed liquid phase from a continuous liquid phase is disclosed.
Patent AU-2014232335-B2 (AU)
Title: Synthetic immunogens for prophylaxis or treatment of tuberculosis
Inventor: WEINER DAVID B
IPC: C12N1/20
Filed: 2014-03-17
Granted: 2016-05-19
Abstract: Compositions comprising a nucleic acid molecule that encodes TB esat-6 proteins are disclosed. Methods of inducing an immune response against TB an individual are disclosed. Method of treating an individual who has been diagnosed with TB are disclosed. Method of preventing TB infection in an individual are disclosed.
Patent AU-2014240359-B2 (AU)
Title: Methods of using sustained release aminopyridine compositions
Inventor: BLIGHT ANDREW R
IPC: A61K31/44
Filed: 2014-10-08
Granted: 2016-09-08
Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition. See Figure 10. WO 2005/099701 PCT/US2005/012427 35- Treatment means over time ** 30 ---------------------------- -- - - -- - ----- - - - 25-- ------------------**------ 20 --2---5- - - - -0V) -0- Placebo (N=47) i 15 ----------- -- Farypridine Non-responders (N=100) --- Farrpridine Responders (N=58) 10 - -- - 50 --- - - - - - - - - - - - - - - - - - - - - - - - - - -5 - -------------- - - -10 titration 1st stable 2nd stable 3rd stable *: Significantly better than placebo and fampridine non-responders (p <0.001 for each). *: Significantly better than fampridine non-responders. Fig. 10